Concepedia

David Okrongly

DO

13

Publications

775

Citations

12

H-Index

1980

Active since

Affiliations

Bayer (United States)(Current)

Memorial Sloan Kettering Cancer Center

Royal London Hospital

OPKO Health (United States)

Tufts University

David Okrongly is an author at Bayer (United States) specializing in medicine, hematology, and immunology.

Top concepts

MedicineHematologyImmunologyHealthClinical SciencesCell BiologyInflammationPharmacologyAtherosclerosisVascular Biology

Publications per year

1980–2018

13

Publications

13

Evaluation of the Anticoagulants EDTA and Citrate, Theophylline, Adenosine, and Dipyridamole (CTAD) for Assessing Platelet Activation on the ADVIA 120 Hematology System

Marion G. Macey, Urooj Azam, D. McCarthy et al. · Clinical Chemistry · 2002 · 152 citations

A model for asymmetric induction in the Diels-Alder reaction

Barry M. Trost, David Okrongly, John L. Belletire · Journal of the American Chemical Society · 1980 · 150 citations

Altmetrics, Engineering, Donut Icon +15

RAPID ISOLATION OF HUMAN CD34 HEMATOPOIETIC STEM CELLS—PURGING OF HUMAN TUMOR CELLS

Jane Lebkowski, Lisa R. Schain, David Okrongly et al. · Transplantation · 1992 · 88 citations

Cell Therapy, Immunology, Blood Cell +17

Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system

M. G. Macey, E Carty, Lee Webb et al. · Cytometry · 1999 · 83 citations

Immunology, Blood Cell, Dermatology +25

Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system

M. G. Macey, E Carty, Lee Webb et al. · Cytometry · 1999 · 81 citations · Full text

Immunology, Blood Cell, Dermatology +25

Rows per page

1–5 of 13